We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Autosomal Recessive Cerebellar Ataxia 3 Due to Homozygote c.132dupA Mutation Within the ANO10 Gene—Reply

Michel Koenig, MD, PhD1; Christine Tranchant, MD2; Mathieu Anheim, MD, PhD2
[+] Author Affiliations
1Laboratoire de Génétique de Maladies Rares, Laboratoire de Génétique Moléculaire, Centre Hospitalo–Universitaire de Montpellier, Institut Universitaire de Recherche Clinique, Université de Montpellier, Montpellier, France
2Département de Neurologie, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg, France
JAMA Neurol. 2015;72(2):239. doi:10.1001/jamaneurol.2014.3921.
Text Size: A A A
Published online


In Reply We identified the c.132dupA mutation of anoctamin 10 (ANO10), coding for an 8 transmembrane putative chloride channel, as being the most frequent mutation causing autosomal recessive cerebellar ataxia type 3 (ARCA3).1 In an attempt to explain why all of our 4 c.132dupA independent cases were compound heterozygous with another ANO10 mutation, rather than being homozygous (which is commonplace for rare recessive disorders), we speculated that c.132dupA homozygote carriers might present with a significantly more severe phenotype (which did not enter our screening criteria) or might not be viable at all. Our identification of a fifth family (M. Koenig and Erik-Jan Kamsteeg; unpublished observation; October 2014) and the publication of 2 additional families with a compound heterozygous c.132dupA mutation2 was consistent with this prediction. However, the discovery of a c.132dupA homozygous family with typical ARCA3 presentation by Minnerop and Bauer, together with the report of another c.132dupA homozygous family identified in an exome cohort of ataxic patients,3 demonstrate that this is not the case but confirm that c.132dupA (also variably named c.123_124insA,3 c.132_133insA, and c.132_133insT2) is definitively the most common ARCA3 mutation.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





February 1, 2015
Martina Minnerop, MD; Peter Bauer, MD
1Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich GmbH, Jülich, Germany
2Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany
JAMA Neurol. 2015;72(2):238-239. doi:10.1001/jamaneurol.2014.3918.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...